4,425 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP bought a new position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 4,425 shares of the medical instruments supplier's stock, valued at approximately $614,000.

A number of other hedge funds have also bought and sold shares of the business. American Century Companies Inc. increased its position in shares of ICU Medical by 8.4% during the 4th quarter. American Century Companies Inc. now owns 3,101 shares of the medical instruments supplier's stock valued at $481,000 after purchasing an additional 241 shares during the last quarter. LPL Financial LLC increased its position in shares of ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock valued at $747,000 after purchasing an additional 93 shares during the last quarter. Norges Bank purchased a new stake in shares of ICU Medical during the 4th quarter valued at about $40,151,000. Pictet Asset Management Holding SA increased its position in shares of ICU Medical by 11.8% during the 4th quarter. Pictet Asset Management Holding SA now owns 3,287 shares of the medical instruments supplier's stock valued at $510,000 after purchasing an additional 346 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC purchased a new stake in shares of ICU Medical during the 4th quarter valued at about $249,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Stock Performance

ICU Medical stock traded down $1.04 during midday trading on Tuesday, hitting $129.02. The stock had a trading volume of 330,735 shares, compared to its average volume of 191,919. The firm's fifty day moving average is $130.64 and its two-hundred day moving average is $141.16. The company has a market capitalization of $3.18 billion, a PE ratio of -33.69 and a beta of 0.88. ICU Medical, Inc. has a 52-week low of $119.19 and a 52-week high of $196.26. The company has a current ratio of 2.59, a quick ratio of 1.52 and a debt-to-equity ratio of 0.75.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The business had revenue of $599.49 million during the quarter, compared to analyst estimates of $574.15 million. During the same period last year, the firm posted $0.96 EPS. The company's revenue was up 6.7% on a year-over-year basis. On average, research analysts forecast that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ICUI. Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. Raymond James Financial cut their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research note on Friday, May 9th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Finally, KeyCorp reduced their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $192.67.

Insider Activity at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 4,985 shares of the stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total transaction of $640,572.50. Following the completion of the sale, the chief operating officer directly owned 6,088 shares of the company's stock, valued at $782,308. This trade represents a 45.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Elisha W. Finney sold 600 shares of the stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $138.92, for a total value of $83,352.00. Following the transaction, the director owned 3,252 shares of the company's stock, valued at $451,767.84. This represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 36,097 shares of company stock valued at $4,860,156. Corporate insiders own 1.50% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.